FY24 facilities to a - 126615 conversion of animal room
Ended Awarded Last action
- Contract number
- 75N91024F00017
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $341,379
Award facts
- Contract value 100% obligated
- $341,379.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$45,237 | |
| Terminate for Convenience | $0 | |
| Original award | $386,616 |
About this award
The National Cancer Institute awarded a delivery order contract to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., for the conversion of an animal room at the Frederick, Maryland facility. This Cost Plus Fixed Fee delivery order, valued at $341,379, was awarded on May 20, 2024, with an ultimate completion date of January 22, 2026. The contract was not issued under any set-aside designation. Leidos Biomedical Research Inc. operates as a Federally Funded Research and Development Center (FFRDC) contractor specializing in comprehensive biomedical research and facilities support services, making the company well-positioned to execute facility infrastructure improvements that support NCI's research operations.
As part of NCI's facilities modernization efforts and consistent with the Department of Government Efficiency cost efficiency initiatives, this project addresses critical infrastructure needs at the Frederick National Laboratory for Cancer Research. The animal facility conversion work represents the type of specialized facilities management and infrastructure support that Leidos Biomedical Research Inc. routinely provides to NCI and the broader National Institutes of Health enterprise. The company's extensive experience managing complex laboratory environments and research infrastructure positions it to deliver this conversion work on schedule and within the established budget parameters.
Quick answers
Who was awarded contract 75N91024F00017?
75N91024F00017 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on May 20, 2024.
How much is contract 75N91024F00017 worth?
The government has obligated $341,379 on 75N91024F00017.
Is contract 75N91024F00017 an order under another contract?
Yes. 75N91024F00017 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91024F00017 competed?
The extent of competition for 75N91024F00017 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award